𝐁𝐢𝐨-𝐛𝐚𝐬𝐞𝐝 𝟑-𝐇𝐏 𝐫𝐨𝐮𝐭𝐞 𝐭𝐨 𝐚𝐜𝐫𝐲𝐥𝐢𝐜 𝐚𝐜𝐢𝐝 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐛𝐲 𝐍𝐎𝐑𝐎𝐎 𝐆𝐫𝐨𝐮𝐩 𝐢𝐧 𝐊𝐨𝐫𝐞𝐚
NOROO Group is accelerating its efforts to preoccupy the industrial biotech market by developing '3-HP (#3Hydroxypropionic Acid),' a next-generation bio-platform material. #NOROOHoldings recently announced that it has been finalized as the executing institution for the project titled "Raw Material Production and Product High-Valueization Technology Development for Activating the #BioBased Polymer Market," which is hosted by the Korea Evaluation Institute of Industrial Technology (#KEIT).
3-HP is one of the "Top 12 Future Bio-Based Chemicals" ed by the US Department of Energy (DOE) and is a core material capable of being converted into various chemical structures, ranging from cosmetics to coatings and eco-friendly plastics. As an eco-friendly material that can replace existing petroleum-based chemical materials, it is evaluated as one of the key materials in the 'industrial biotech (white biotech)' business for the carbon-neutral era.
In this project, NOROO Holdings will oversee the entire process from securing raw materials to production, conducting mass-production validation of 3-HP using waste biomass.
The key sub-projects include:
▲Development of bio-based acrylic acid-based polymer materials,
▲Mass-production validation of 3-HP utilizing waste biomass, and ▲Validation of #bioacrylicacid production based on 3-HP catalytic reactions.
Synergy effects within the group are also expected. NOROO Paint, the major affiliate, will take charge of the project "Validation of Bio-Acrylic Acid Production Based on 3-HP Catalytic Reactions." It will the process of converting 3-HP into an industrial raw material and research the feasibility of replacing acrylic acid—which has previously relied entirely on petrochemical processes—with bio-based materials. Notably, this project plans to focus on securing a "total value chain" from raw material production to the final product through industry-academia-research collaboration involving multiple joint research institutions.
An official from the Noroo Bio Business Development Division stated, "While the industrial biotech field has previously focused primarily on research (R), this validation project signifies a full-scale advancement into the development and commercialization (D) stage, accompanied by actual pilot facility investments." The official added, "We will continue to strive to expand development projects for industrial biotech materials in cooperation with the Ministry of Trade, Industry and Energy (MOTIE) in the future.
source : NOROO Group

Comments
Post a Comment